Evidence Synthesis
Gangapharm's quarterly performance has shown significant improvement in its gross margin, accelerating to 53.65%, up from 2.15%.
The company's revenue growth year-over-year has slowed, decelerating to , down from 104.8%.
On a daily basis, the company's daily trading volume has increased substantially, moving from 253 shares to 16,000 shares. However, the close price has remained unchanged, at 12.5 INR. The marginal operating leverage has also shown a decline, decreasing to , down from 3.59%.